SEX HETEROGENEITY IN PHARMACOGENETIC SMOKING CESSATION CLINICAL TRIALS
Saved in:
SCHNOLL, R.A., PATTERSON, F., SEX HETEROGENEITY IN PHARMACOGENETIC SMOKING CESSATION CLINICAL TRIALS. DRUG AND ALCOHOL DEPENDENCE, Vol. 104, no. SUPL.1 (2009), p. S94-S99.
Ref.
166133
Location:
SIIS R.854 Archivo
Palabras clave:
Datos epidemiológicos, Drogodependencias, Fármacos, Género, Nicotina de sustitución, Resultados, Tabaquismo, Tratamiento
Datos epidemiológicos, Drogodependencias, Fármacos, Género, Nicotina de sustitución, Resultados, Tabaquismo, Tratamiento
Similar Items: SEX HETEROGENEITY IN PHARMACOGENETIC SMOKING CESSATION CLINICAL TRIALS
- NICOTINE PATCH VS. NICOTINE LOZENGE FOR SMOKING CESSATION: AN EFFECTIVENESS TRIAL COORDINATED BY THE COMMUNITY CLINICAL ONCOLOGY PROGRAM
- COST EFFECTIVENESS OF VARENICLINE COMPARED WITH NICOTINE PATCHES FOR SMOKING CESSATION. RESULS FROM FOUR EUROPEAN COUNTRIES
- Effectiveness of varenicline and cytisine for alcohol use reduction among people with HIV and substance use. A randomized clinical trial
- An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women
- Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study)
- Associations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study